BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 6117919)

  • 1. Neuroleptic-induced acute dyskinesias in rhesus monkeys.
    Porsolt RD; Jalfre M
    Psychopharmacology (Berl); 1981; 75(1):16-21. PubMed ID: 6117919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute dyskinesias in monkeys elicited by halopemide, mezilamine and the "antidyskinetic" drugs, oxiperomide and tiapride.
    Neale R; Fallon S; Gerhardt S; Liebman JM
    Psychopharmacology (Berl); 1981; 75(3):254-7. PubMed ID: 6798615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroleptic-induced acute dyskinesias in squirrel monkeys: correlation with propensity to cause extrapyramidal side effects.
    Liebman J; Neale R
    Psychopharmacology (Berl); 1980; 68(1):25-9. PubMed ID: 6104837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A monitoring test for the liability of neuroleptic drugs to induce tardive dyskinesia.
    Gunne LM; Bárány S
    Psychopharmacology (Berl); 1979 Jun; 63(3):195-8. PubMed ID: 39307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute dystonia induced by neuroleptic drugs.
    Rupniak NM; Jenner P; Marsden CD
    Psychopharmacology (Berl); 1986; 88(4):403-19. PubMed ID: 2871578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The common marmoset (Callithrix jacchus) as a model for neuroleptic-induced acute dystonia.
    Fukuoka T; Nakano M; Kohda A; Okuno Y; Matsuo M
    Pharmacol Biochem Behav; 1997 Dec; 58(4):947-53. PubMed ID: 9408199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of a primate model for tardive dyskinesia.
    Bárány S; Häggström JE; Gunne LM
    Acta Pharmacol Toxicol (Copenh); 1983 Feb; 52(2):86-9. PubMed ID: 6846025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of dopamine agonists, catecholamine depletors, and cholinergic and GABAergic drugs on acute dyskinesias in squirrel monkeys.
    Neale R; Gerhardt S; Liebman JM
    Psychopharmacology (Berl); 1984; 82(1-2):20-6. PubMed ID: 6320248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The dose-response characteristics of rat oral dyskinesias with chronic haloperidol or clozapine administration.
    Gao XM; Hashimoto T; Cooper TB; Tamminga CA
    J Neural Transm (Vienna); 1997; 104(1):97-104. PubMed ID: 9085197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased incidence of dyskinesias and other behavioral effects of re-exposure to neuroleptic treatment in social colonies of Cebus apella monkeys.
    Linn GS; Lifshitz K; O'Keeffe RT; Lee K; Camp-Lifshitz J
    Psychopharmacology (Berl); 2001 Jan; 153(3):285-94. PubMed ID: 11271400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progressive changes in the acute dyskinetic syndrome as a function of repeated elicitation in squirrel monkeys.
    Neale R; Gerhardt S; Fallon S; Liebman JM
    Psychopharmacology (Berl); 1982; 77(3):223-8. PubMed ID: 6126906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Susceptibility to amphetamine-elicited dyskinesias following chronic methadone treatment in monkeys.
    Carlson KR; Eibergen RD
    Ann N Y Acad Sci; 1976; 281():336-49. PubMed ID: 828468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clozapine in tardive dyskinesia: observations from human and animal model studies.
    Tamminga CA; Thaker GK; Moran M; Kakigi T; Gao XM
    J Clin Psychiatry; 1994 Sep; 55 Suppl B():102-6. PubMed ID: 7961550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experimental tardive dyskinesia.
    Gunne LM; Häggström JE
    J Clin Psychiatry; 1985 Apr; 46(4 Pt 2):48-50. PubMed ID: 2858481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Dyskinetic syndromes in psychiatric patients (author's transl)].
    Lutrand JC; Ducamin JP
    Sem Hop; 1978 Dec 18-25; 54(45-46):1465-8. PubMed ID: 34882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Haloperidol-induced tardive dyskinesia in monkeys.
    Gunne LM; Bárány S
    Psychopharmacology (Berl); 1976 Nov; 50(3):237-40. PubMed ID: 826968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of tolerance to haloperidol-induced acute dyskinesias in rhesus monkeys.
    Porsolt RD
    Psychopharmacology (Berl); 1984; 82(1-2):145-6. PubMed ID: 6420826
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparative neurochemical changes associated with chronic administration of typical and atypical neuroleptics: implications in tardive dyskinesia.
    Bishnoi M; Kumar A; Chopra K; Kulkarni SK
    Indian J Exp Biol; 2007 Feb; 45(2):175-9. PubMed ID: 17375557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of sulpiride on persistent neuroleptic-induced dyskinesia in monkeys.
    Häggström JE
    Acta Psychiatr Scand Suppl; 1984; 311():103-8. PubMed ID: 6142586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spontaneous orofacial dyskinesias in a captive cynomolgus monkey: implications for tardive dyskinesia.
    Rupniak NM; Tye SJ; Steventon MJ; Boyce S; Iversen SD
    Mov Disord; 1990; 5(4):314-8. PubMed ID: 2259355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.